Legis Daily

State Opioid Response Grant Authorization Act of 2021

USA117th CongressHR-2379| House 
| Updated: 10/21/2021
David J. Trone

David J. Trone

Democratic Representative

Maryland

Cosponsors (8)
Mikie Sherrill (Democratic)Lisa Blunt Rochester (Democratic)Ann M. Kuster (Democratic)Don Bacon (Republican)James R. Baird (Republican)Kelly Armstrong (Republican)Brian K. Fitzpatrick (Republican)Ted Budd (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
State Opioid Response Grant Authorization Act of 2021 This bill reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes and tribal organizations to address the opioid crisis. Specific changes to the program include (1) expanding its scope to also address stimulant use and misuse, (2) establishing a funding methodology and minimum funding allocations, and (3) allowing the use of grant funds for recovery support services. The bill also requires the Government Accountability Office to report on issues concerning the funding and other aspects of the program.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2466
State Opioid Response Grant Authorization Act of 2020
Apr 8, 2021
Introduced in House
Apr 8, 2021
Referred to the House Committee on Energy and Commerce.
Apr 13, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Oct 19, 2021
Placed on the Union Calendar, Calendar No. 109.
Oct 19, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.
Oct 19, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 19, 2021
Considered under suspension of the rules. (consideration: CR H5647-5650)
Oct 19, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.
Oct 19, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 20, 2021
Considered as unfinished business. (consideration: CR H5699-5700)
Oct 20, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
View Vote
Oct 20, 2021
Motion to reconsider laid on the table Agreed to without objection.
Oct 21, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 13, 2022

Latest Companion Bill Action

S 117-4839
Introduced in Senate
  • Bill from Previous Congress

    HR 116-2466
    State Opioid Response Grant Authorization Act of 2020


  • April 8, 2021
    Introduced in House


  • April 8, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 13, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • October 19, 2021
    Placed on the Union Calendar, Calendar No. 109.


  • October 19, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.


  • October 19, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • October 19, 2021
    Considered under suspension of the rules. (consideration: CR H5647-5650)


  • October 19, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.


  • October 19, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • October 20, 2021
    Considered as unfinished business. (consideration: CR H5699-5700)


  • October 20, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
    View Vote


  • October 20, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • October 21, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • September 13, 2022

    Latest Companion Bill Action

    S 117-4839
    Introduced in Senate

Health

Related Bills

  • S 117-4839: State Opioid Response Grant Authorization Act of 2022
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth care coverage and accessHealth care qualityHealth programs administration and fundingHealth promotion and preventive carePrescription drugsState and local government operations

State Opioid Response Grant Authorization Act of 2021

USA117th CongressHR-2379| House 
| Updated: 10/21/2021
State Opioid Response Grant Authorization Act of 2021 This bill reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes and tribal organizations to address the opioid crisis. Specific changes to the program include (1) expanding its scope to also address stimulant use and misuse, (2) establishing a funding methodology and minimum funding allocations, and (3) allowing the use of grant funds for recovery support services. The bill also requires the Government Accountability Office to report on issues concerning the funding and other aspects of the program.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2466
State Opioid Response Grant Authorization Act of 2020
Apr 8, 2021
Introduced in House
Apr 8, 2021
Referred to the House Committee on Energy and Commerce.
Apr 13, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Oct 19, 2021
Placed on the Union Calendar, Calendar No. 109.
Oct 19, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.
Oct 19, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 19, 2021
Considered under suspension of the rules. (consideration: CR H5647-5650)
Oct 19, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.
Oct 19, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 20, 2021
Considered as unfinished business. (consideration: CR H5699-5700)
Oct 20, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
View Vote
Oct 20, 2021
Motion to reconsider laid on the table Agreed to without objection.
Oct 21, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 13, 2022

Latest Companion Bill Action

S 117-4839
Introduced in Senate
  • Bill from Previous Congress

    HR 116-2466
    State Opioid Response Grant Authorization Act of 2020


  • April 8, 2021
    Introduced in House


  • April 8, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 13, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • October 19, 2021
    Placed on the Union Calendar, Calendar No. 109.


  • October 19, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.


  • October 19, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • October 19, 2021
    Considered under suspension of the rules. (consideration: CR H5647-5650)


  • October 19, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.


  • October 19, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • October 20, 2021
    Considered as unfinished business. (consideration: CR H5699-5700)


  • October 20, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
    View Vote


  • October 20, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • October 21, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • September 13, 2022

    Latest Companion Bill Action

    S 117-4839
    Introduced in Senate
David J. Trone

David J. Trone

Democratic Representative

Maryland

Cosponsors (8)
Mikie Sherrill (Democratic)Lisa Blunt Rochester (Democratic)Ann M. Kuster (Democratic)Don Bacon (Republican)James R. Baird (Republican)Kelly Armstrong (Republican)Brian K. Fitzpatrick (Republican)Ted Budd (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-4839: State Opioid Response Grant Authorization Act of 2022
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth care coverage and accessHealth care qualityHealth programs administration and fundingHealth promotion and preventive carePrescription drugsState and local government operations